Contact UsInvestorsCareersMediaScienceContact Us
HomeOur VoiceReflecting on Rare Disease Day 2021

By Fred Little, Rare Disease Canada Lead, Pfizer Canada

Rare Disease Day may only happen once a year, though it offers us an opportunity to remind those living with rare diseases that they are never alone – myself and others at Pfizer are here to support them every step of the way, every day of the year.

While inherently uncommon, rare diseases collectively impact approximately 300 million people around the world – including the family and loved ones of the patients themselves: people like our Pfizer colleague, Kathleen.

In December of last year, Kathleen’s father received blood work and an electrocardiogram, which necessitated a trip to the hospital for further tests. At first, health care practitioners struggled to properly diagnose him until Kathleen – drawing on her skills as a nurse and her knowledge of her father – stepped in to assist, ultimately leading to a diagnosis of the rare disease, ATTR-CM.

Not everyone has that type of support – that’s where we, at Pfizer, can help. We aspire to enable rare disease innovation and pioneer transformative science; it’s been our mission for more than 30 years.

I’m so proud of the strides we’ve made and I’m excited to see the efforts we’re now making come to fruition. That’s why it’s so important to have a Rare Disease Framework that will ensure access to safe and effective therapies for patients with rare diseases.

Of course, this will take a shared effort, including collaboration with patient groups, continued investment in research and development, and improved access to medicine. Together, we can make a real, lasting, positive difference for patients, on Rare Disease Day and beyond.  

To learn more about the importance of a Rare Disease Framework, please visit the Canadian Organization for Rare Disorders or the Regroupement Québécois des maladies orphelines for Quebec.

Young Leader Inspires and Engages Pfizer Canada Colleagues 

Drug Shortage Lessons Learned: How do we build a more resilient injectable medicines market in Canada?

Our Environmental, Social and Governance (ESG) Performance

Advancing Diversity at Pfizer Canada

The importance of supporting a resilient life sciences eco-system in Canada

Pfizer Highlights Commitment to All Patients During Patients in Focus Week

“My Voice, Our Equal Future”

In My Words: Effie’s Life with Ulcerative Colitis

Unleashing the power of its people makes Pfizer a top employer

Hope and Optimism While Living With Ulcerative Colitis

Marking Rare Disease Day 2022: Why Every Minute Matters 

In Conversation with Barry Stein

In Conversation with Filomena Servidio-Italiano

A commitment to creating a culture of inclusivity at Pfizer Canada

Pfizer announces recipients of research grants focused on transthyretin amyloid cardiomyopathy in Canada 

Canada’s Research-Based Pharmaceutical Industry is a Significant Contributor to the Economy

World Hemophilia Day: Robbie’s journey highlights the importance of raising awareness and finding community

Listening and Learning from Patients Living with Bladder Cancer

Pfizer Canada’s recommendations regarding the development of a National Strategy for Drugs for Rare Diseases

A Conversation with Najah Sampson

Living Well with Rheumatoid Arthritis (RA): Getting to the Heart of the Matter

Vaccine And Immunization Facts

Understanding Biosimilars

Girls Belong Here at Pfizer Canada

Giving Back – Pfizer Canada’s Month of Giving 

Pfizer Colleagues Get Healthy with the VIVA Health & Wellness program

Carpe Diem: Rise in Remote Connecting a Boon for those Living with RA

Imagine RA Network: Chronic Illness in a Pandemic Life

CDHF and Pfizer: The power of collaboration in the ulcerative colitis space

Reflecting on Rare Disease Day 2021

A Day in the Life with Atopic Dermatitis by Pfizer Colleague Kerri
About UsOur ProductsHelping Communities Our Voice Suppliers Distribution ChannelPfizer WorldwideMedia CentreTerms Of Use Careers Healthcare ProfessionalsContact UsPrivacy PolicyCopyright © Pfizer Canada 2022 All rights reserved. The information is intended only for residents of Canada. ® Pfizer Inc, used under license